Cargando…
Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18
BACKGROUND: Thiazolidinone derivatives show inhibitory activity (IC(50)) against the Toxoplasma gondii parasite, as well as high selectivity with high therapeutic index. To disclose the target proteins of the thiazolidinone core in this parasite, we explored in silico the active sites of different T...
Autores principales: | Molina, Diego, Cossio-Pérez, Rodrigo, Rocha-Roa, Cristian, Pedraza, Lina, Cortes, Edwar, Hernández, Alejandro, Gómez-Marín, Jorge E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267824/ https://www.ncbi.nlm.nih.gov/pubmed/30497375 http://dx.doi.org/10.1186/s12864-018-5223-7 |
Ejemplares similares
-
In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii
por: Molina, Diego A., et al.
Publicado: (2021) -
Enzyme-Linked Aptamer Assay (ELAA) for Detection of Toxoplasma ROP18 Protein in Human Serum
por: Vargas-Montes, Monica, et al.
Publicado: (2019) -
The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18
por: Behnke, Michael S., et al.
Publicado: (2012) -
Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection
por: Hernández-de-los-Ríos, Alejandro, et al.
Publicado: (2019) -
ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii
por: El Hajj, Hiba, et al.
Publicado: (2007)